In our study, we investigated the role of IFI30 expression in tumorigenesis and progression, as well as its impact on the prognosis of ccRCC, utilizing diverse databases such as TCGA and the HPA. The gene discussed is IFI30; the disease is nonpapillary renal cell carcinoma.